Pharmacy Practice and Pharmaceutical Sciences

Keyphrases

1. Pharmacist 100%
2. Pharmacy Students 41%
3. Pharmacy 30%
4. Thyroid Hormones 24%
5. Minnesota 23%
6. United States 22%
7. College of Pharmacy 20%
8. Patient Care 20%
9. Pharmacy Practice 17%
10. Pharmacy School 17%
11. Native American 17%
12. Pharmacogenetics 15%
13. University of Minnesota 14%
14. Lactate Dehydrogenase-elevating Virus 13%
15. Pharmacogenomics 13%
16. Primary Care 13%
17. Pharmacy Education 13%
18. Healthcare Professionals 13%
19. Escherichia Coli 13%
20. Biological Evaluation 12%
21. Cytochrome c (Cyt c) 12%
22. Novel Anticancer Agent 12%
23. Laminin 11%
24. Synthetic Evaluation 11%
25. Public Health 11%
26. Pharmacy Curriculum 11%
27. Antipsychotics 11%
28. Older Adults 11%
29. Postgraduate Year 11%
30. Metastatic Renal Cell Carcinoma (mRCC) 10%
31. Pharmacist Role 10%
32. Rural Communities 10%
33. Brain Development 10%
34. Patient-centered 10%
35. Medication Therapy Management 10%
36. Opioid Crisis 9%
37. Student Pharmacists 9%
38. Health Disparities 9%
39. Community Pharmacy 9%
40. Pharmaceutical Care 9%
41. Chemotherapy 9%
42. Overall Survival 9%
43. Health Systems 8%
44. African American Women 8%
45. Ambulatory Care 8%
46. Drosophilidae 8%
47. Healthcare 8%
48. Family Medicine 8%
49. British Columbia 7%
50. Community Pharmacists 7%
51. Atomoxetine 7%
52. Cytochrome P450 2D6 (CYP2D6) 7%
53. Medication Use 7%
54. Naloxone 7%
55. Pharmacogenetic Testing 7%
56. Menthol 7%
57. Advanced Pharmacy Practice Experience 7%
58. Competencies 7%
59. Cytochrome 7%
60. Pharmacist Attitudes 7%
61. Anticancer Agents 7%
62. Mental Health 7%
63. Opioids 6%
64. Progression-free Survival 6%
65. Medical Assistance in Dying (MAiD) 6%
66. Cytochrome bo3 6%
67. Monocarboxylate Transporter 1 (MCT1) 6%
68. Morphine 6%
69. Cultural Competency 6%
70. Caregivers 6%
71. Blood-brain Barrier 6%
72. KATP Channel 6%
73. Medication Management Services 6%
74. Heme 6%
75. Survey Data 6%
76. Interprofessional Teams 6%
77. Preceptor 6%
78. Residency 6%
79. Treatment Patterns 6%
80. Confidence Interval 6%
81. Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 6%
82. Pericytes 6%
83. Diabetes 6%
84. Precision Medicine 5%
85. Glioblastoma 5%
86. Thyroid Hormone Action 5%
87. Pharmacotherapy 5%
88. Spot14 5%
89. US Adults 5%
90. Community-based 5%
91. Doctor of Pharmacy 5%
92. Thyroxine 5%
93. PGx Testing 5%
94. American Indian or Alaska Native 5%
95. Folding Pathway 5%
96. Low-income 5%
97. Clinical Practice 5%
98. Survival Outcomes 5%
99. Type 2 Diabetes Mellitus (T2DM) 5%
100. Collaborative Practice 5%